Publications by authors named "Ronald Natale"

Claim this Profile
L
Low booster uptake in cancer patients despite health benefits.
Jane C Figueiredo, Julia Levy, So Yung Choi, Alexander M Xu, Noah M Merin, Ronald Natale

iScience· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low booster uptake in cancer patients despite health benefits.
Jane C Figueiredo, Julia Levy, So Yung Choi, Alexander M Xu, Noah M Merin, Ronald Natale

medRxiv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy Outcomes From a Single-Center Study of Image-Guided Percutaneous Microwave Ablation for Primary and Metastatic Lung Malignancy.
Stephen M Chan, Peter J Julien, Peter Kaganjo, Robert J McKenna, Charles Forscher, Ronald Natale

JTO Clin Res Rep· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study.
Jun Gong, Michelle Guan, Haesoo Kim, Natalie Moshayedi, Sejal Mehta, Ronald B Natale

Oncotarget· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer (MYSTIC).
Edward B Garon, Byoung Chul Cho, Niels Reinmuth, Ki Hyeong Lee, Alexander Luft, Ronald Natale

Clin Lung Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three Primary Tumors Including EGFR-mutated Non-Small Cell Lung Cancer as First Presentation in Patient With Li-Fraumeni Syndrome.
Arjan Gower, Jong Kim, Kellie Spector, Daniella Menashe, Eric Vail, Ronald Natale

Clin Lung Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial.
Naiyer A Rizvi, Byoung Chul Cho, Niels Reinmuth, Ki Hyeong Lee, Alexander Luft, Ronald Natale

JAMA Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study.
James C H Yang, Sang-We Kim, Dong-Wan Kim, Jong-Seok Lee, Byoung Chul Cho, Ronald B Natale

J Clin Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Genotyping of Matched Urine, Plasma, and Tumor Tissue in Patients With Non-Small-Cell Lung Cancer Treated With Rociletinib, an Tyrosine Kinase Inhibitor.
Jonathan W Goldman, Chris Karlovich, Lecia V Sequist, Vlada Melnikova, Aleksandra Franovic, Ronald B Natale

JCO Precis Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
Fred R Hirsch, Keith M Kerr, Paul A Bunn, Edward S Kim, Coleman Obasaju, Ronald B Natale

Clin Lung Cancer· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors.
David M Hyman, Naiyer Rizvi, Ronald Natale, Deborah K Armstrong, Michael Birrer

Clin Cancer Res· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer.
Mark A Socinski, Coleman Obasaju, David Gandara, Fred R Hirsch, Philip Bonomi, Ronald B Natale

J Thorac Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study.
Myung-Ju Ahn, Dong-Wan Kim, Byoung Chul Cho, Sang-We Kim, Jong Seok Lee, Ronald Natale

Lancet Respir Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors.
Monica Mita, Siqing Fu, Sarina Anne Piha-Paul, Filip Janku, Alain Mita, Ronald Natale

Invest New Drugs· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers.
Helena A Yu, Myung-Ju Ahn, Byoung Chul Cho, David E Gerber, Ronald B Natale

Lung Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
David R Spigel, Alexander Luft, Henrik Depenbrock, Rodryg Ramlau, Mazen Khalil, Ronald Natale

Clin Lung Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment.
Corey J Langer, Coleman Obasaju, Paul Bunn, Philip Bonomi, David Gandara, Ronald B Natale

J Thorac Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I, First-in-Human Study of AMG 780, an Angiopoietin-1 and -2 Inhibitor, in Patients with Advanced Solid Tumors.
Afshin Dowlati, Gordana Vlahovic, Ronald B Natale, Erik Rasmussen, Indrajeet Singh

Clin Cancer Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic Features of Advanced Squamous NSCLC.
Mark A Socinski, Coleman Obasaju, David Gandara, Fred R Hirsch, Philip Bonomi, Ronald B Natale

J Thorac Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic study of aldoxorubicin in patients with solid tumors.
Monica M Mita, Ronald B Natale, Edward M Wolin, Brenda Laabs, Hillary Dinh

Invest New Drugs· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II study.
Ronald Natale, Fiona Blackhall, Dariusz Kowalski, Rodryg Ramlau, Gerold Bepler

J Thorac Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer.
Christelle Clément-Duchêne, Ronald B Natale, Thierry Jahan, Yelena Krupitskaya, Raymond Osarogiagbon

Lung Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer.
Crystal T Pike, Howard G Birnbaum, Catherine E Muehlenbein, Gerhardt M Pohl, Ronald B Natale

Chemother Res Pract· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer.
Radj Gervais, John D Hainsworth, Normand Blais, Benjamin Besse, Janessa Laskin, Ronald B Natale

Lung Cancer· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer.
Ronald B Natale, Sumitra Thongprasert, F Anthony Greco, Michael Thomas, Chun-Ming Tsai

J Clin Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis